MELBOURNE, Australia and SAN FRANCISCO, Jan. 3, 2023 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that David...
News Ticker
- [ January 31, 2023 ] Scientist, Immuno-Oncology – Eureka Therapeutics – Emeryville, CA San Francisco Biotech Jobs
- [ January 31, 2023 ] Town Hall Ventures’ Andy Slavitt on how to invest in Medicaid and health tech News
- [ January 31, 2023 ] Scientist I (CMC) – Exelixis, Inc. – Alameda, CA San Francisco Biotech Jobs
- [ January 31, 2023 ] West Coast Territory Manager (BioTech Company – PHD in Biology Preferred) – VectorBuilder Inc. – San Francisco Bay Area, CA San Francisco Biotech Jobs
- [ January 31, 2023 ] Senior Scientist – Bio-Rad Laboratories, Inc. – Hercules, CA San Francisco Biotech Jobs
Copyright © 2022 Biotech Networks, LLC
